The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: Systematic review and meta-analysis

BACKGROUND: The evidence of using JAK inhibitors among hospitalized patients with COVID-19 is conflicting. The systematic review and meta-analysis aimed to address the efficacy of Janus Kinase (JAK) Inhibitors in reducing risk of mortality among hospitalized patients with COVID-19. METHODS: Several...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijaya, Indra, Andhika, Rizky, Huang, Ian, Purwiga, Aga, Budiman, Kevin Yonatan, Bashari, Muhammad Hasan, Reniarti, Lelani, Roesli, Rully Marsis Amirullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. on behalf of INDIACLEN. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088409/
https://www.ncbi.nlm.nih.gov/pubmed/33969237
http://dx.doi.org/10.1016/j.cegh.2021.100755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088409/
https://www.ncbi.nlm.nih.gov/pubmed/33969237
http://dx.doi.org/10.1016/j.cegh.2021.100755

Ejemplares similares